Reet Mändar

Prof. Reet Mändar

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2005 in Oral Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
PKP. Kõll‐Klais
P. Kõll‐Klais
RMReet Mändar
Reet Mändar
ELE. Leibur
E. Leibur
HMH. Marcotte
H. Marcotte
LHL. Hammarström
L. Hammarström
MMM. Mikelsaar
M. Mikelsaar

1 June 2015 in Research in Microbiology
Verified
Journal Article
Closed access
RMReet Mändar
Reet Mändar
MPMargus Punab
Margus Punab
NBNatalja Borovkova
Natalja Borovkova
ELEleri Lapp
Eleri Lapp
RKRiinu Kiiker
Riinu Kiiker
Jaak TruuJaak Truu
Jaak Truu

15 November 2019 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
SASigne Altmäe
Signe Altmäe
JFJason M. Franasiak
Jason M. Franasiak
RMReet Mändar
Reet Mändar

4 August 2005 in Nutrition Journal
Verified
Journal Article
Open access
ESEpp Songisepp
Epp Songisepp
JKJaak Kals
Jaak Kals
TKTiiu Kullisaar
Tiiu Kullisaar
RMReet Mändar
Reet Mändar
PHPirje Hütt
Pirje Hütt
MMMarika Mikelsaar
Marika Mikelsaar
Background: In persons without clinical symptom it is difficult to assess an impact of probiotics regarding its effect on health. We evaluated the functional efficacy of the probiotic Lactobacillus fermentum ME-3 in healthy volunteers by measuring the influence of two different formulations on intestinal lactoflora, fecal recovery of the probiotic strain and oxidative stress markers of blood and urine after 3 weeks consumption. Methods: Two 3-week healthy volunteer trials were performed. Open placebo controlled (OPC) study participants (n = 21) consumed either goat milk or by L. fermentum ME-3 fermented goat milk (daily dose 11.8 log CFU (Colony Forming Units). Double blind randomised placebo controlled (DBRP) study participants (n = 24) received either capsules with L. fermentum ME-3 (daily of dose 9.2 CFU) or placebo capsules. The faecal lactoflora composition, faecal ME-3 recovery, effect of the consumption on intestinal lactoflora, and oxidative stress markers of blood (total antioxidative activity; total antioxidative status and glutathione red-ox ratio) was measured. Results: ME-3 was well tolerated and a significant increase in total faecal lactobacilli yet no predominance of ME-3 was detected in all study groups. Faecal recovery of ME-3 was documented by molecular methods only in fermented milk group, however the significant improvement of blood TAA (Total Antioxidative Activity) and TAS (Total Antioxidative Status) indices was seen both in case of fermented goat milk and capsules", yet glutathione re-ox ratio values decreased only in case of fermented by ME-3 goat milk. Conclusion: The functional efficacy of both consumed formulations of an antioxidative probiotic L. fermentum ME-3 is proved by the increase of the intestinal lactobacilli counts providing putative defence against enteric infections and by reduction of the oxidative stress indices of blood and urine of healthy volunteers. In non-diseased host the probiotic health claims can be assessed by improvement of some measurable laboratory indices of well-established physiological functions of host, e.g. markers of antioxidative defence system.

1 February 2017 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
RMReet Mändar
Reet Mändar
MPMargus Punab
Margus Punab
PKPaul Korrovits
Paul Korrovits
STSilver Türk
Silver Türk
KAKristo Ausmees
Kristo Ausmees
JTJaak Truu
Jaak Truu

1 March 2013 in Pharmacological Research
Verified
Journal Article
Closed access
RMReet Mändar
Reet Mändar